An evaluation of fMLP pocket dimensions and features using formyltetrapeptides

Journal of Peptide Research

Volumn 54, Issue 4, 1999, Pages 336-343

  Cavicchioni, Giorgio ^a,b   Varani, K ^a   Niccoli, S ^a   Rizzuti, O ^a   Spisani, S ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Dept of Pharmaceutical Sci U ^*  (Italy)

Author keywords

Binding affinity; Formylpeptides; Human neutrophils; Structure activity relationship

Indexed keywords

FORMYLPEPTIDE; GLUCOSE; LYSOZYME; PEPTIDE; SUPEROXIDE; TRIFLUOROACETIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CHEMOTAXIS; DATA ANALYSIS; PEPTIDE SYNTHESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING;

AMINO ACID SEQUENCE; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; CYTOPLASMIC GRANULES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MURAMIDASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES;

EID: 0032888720     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00106.x     Document Type: Article

References (26)

1. 1. Snyderman, R. & Pike, M.C. (1984) Chemoattractant receptors on phagocytic cells. Annu. Rev. Immunol, 2, 257-281.
2. 2. Snyderman, R. (1985) Regulatory mechanisms of a chemoattractant receptor on human polymorphonuclear leukocytes. Rev. Infect. Dis. 7, 390-394.
3. 3. Iizawa, O., Akamatsu, H. & Niwa, Y. (1995) Neutrophil chemotaxis, phagocytosis, and generation of reactive oxygen species show a hierarchy of responsiveness to increasing concentrations of N-formyl-Met-Leu-Phe. Biol. Signals 4, 14-18.
4. 4. Spisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Pagani Zecchini, G., Paglialunga Paradisi, M., Torrini, I. & Ferretti, M.E. (1996) Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cell. Signal 8, 269-277.
5. 5. Schiffmann, E., Corcoran, B.A. & Wahl, S.M. (1975) N-Formylmethionyl peptides as chemoattractants for leukocytes. Proc. Natl Acad. Sci. USA 72, 1059-1062.
6. 6. Becker, E.L. (1987) The formylpeptide receptor of the neutrophil. A search and conserve operation. Am. J. Pathol. 129, 16-24.
7. 7. Hoffman, J.F., Keil, M.L., Riccobene, T.A., Omann, G.M. & Linderman, J.J. (1996) Interconverting receptor states at 4°C for the neutrophil N-formyl peptide receptor. Biochemistry 35, 13047-13055.
8. 8. Murphy, P.M. (1994) The molecular biology of leucocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633.
9. 9. Ferretti, M.F., Spisani, S., Pareschi, M.C., Buzzi, M., Cavallaro, R., Traniello, S., Reali, E., Torrini, I., Paglialunga Paradisi, M., Pagani Zecchini, G. & Biondi, C., (1994) Two new formylated peptides able to activate chemotaxis and respiratory burst selectively as tools for studying human neutrophil responses. Cell. Signal. 6, 91-101.
10. 2+. Biochem. Biophys. Acta 1359, 233-240.
11. 11. Ye, R.D., & Boulay, F. (1997) Structure and function of leukocyte chemoattractant receptor, Adv. Pharmacot. 39, 221-289.
12. 12. Koo, C., Lefkowitz, R.J. & Snyderman, R. (1982) The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem. Biophys. Res. Commun. 106, 442-449.
13. 13. Sklar, L.A., Fay, S.P., Seligmann, B.E., Freer, R.J., Muthukumaraswamy, N. & Mueller, H. (1990) Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance. Biochemistry 29, 313-316.
14. 14. Raj, P.A., Dentino, A.R., Situ, Z. & Levine, M.J. (1992) Structural requirements for chemotactic peptide receptor activation. American Crystallographic Association, 50th Annual Meeting PA19, 87.
15. 15. Rot, A., Henderson, L.E., Copeland, T.D. & Leonard, E.L. (1987) A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy. Proc. Natl Acad. Sci. USA 84, 7967-7971.
16. 16. Freer, R.J., Day, A.R., Radding, J.A., Schiffmann, E., Aswanikumar, S., Showell, H.J. & Becker, E.L. (1980) Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 19, 2404-2410.
17. 17. Spisani, S., Breveglieri E., Fabbri, E., Vertuani, G., Rizzuti, O. & Cavicchioni, G. (1996) Modification of the amide bond at position 3 in fMLP analogs select neutrophil functions. Peptide Res. 9, 279-282.
18. 18. Cavicchioni, G., Breveglieri, A., Boggian, M., Vertuani, G., Rcali, E. & Spisani, S. (1996) The importance of peptide bond at position 2 in fMLP-OMc analogues focused by studies on human neutrophils. J. Peptide Sci. 2, 135-140.
19. 19. Boulay, F., Tardiff, M., Brouchon, L. & Vignais, P. (1990) Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. 168, 1103-1109.
20. 20. Kermode, C., Freer, J.R. & Becker, L. (1991) The significance of functional receptor heterogeneity in the biological responses of the rabbit neutrophil to stimulation by chemotactic formyl peptides. Biochem. J. 276, 715-723.
21. 21. Dentino, A.R., Antony Ray, P. & Dc Nardin, E. (1997) Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides. Arch. Biochem. Biophys. 337, 267-274.
22. 22. Moroder, L., Hallet, A., Wünsch, E., Keller, O. & Wersin, G. (1976) Di-tert-butyldicarbonat-Einvorteilhafter Reagenz zur Einfuhring der tert-Butyloxycarbonyl-Schutzgruppe. Hoppe Seylers Z. Physiol. Chem. 357, 1651-1653.
23. 23. Anderson, G.W., Zimmerman, J.E. & Callahan, F.M. (1967) A reinvestigation of the mixed carbonic anhydride method of peptide synthesis. J. Am. Chem. Soc. 89, 5012-5017.
24. 24. Konig, W. & Geiger, R. (1970) Eine neue Methode zur Synthese von Peptiden: aktivicrung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1-Hydroxybenzotriazolen. Chem. Ber. 103, 788-798.
25. 25. Lajoic, G. & Kraus, J.L. (1984) Rapid and efficient method for the N-formylation of C-blocked peptides. Peptide 5, 653-654.
26. 26. Zigmond, S.H. & Hirsh, J.G. (1973) Leukocyte locomotion and chemotaxis. New method for evaluation and demonstration of a cell derived chemotactic factor. J. Exp. Med. 137, 387-410.